Successful Infliximab Therapy in a Patient with Refractory Takayasu's Arteritis
Journal of Rheumatic Diseases
;
: 71-75, 2016.
Artigo
em Inglês
| WPRIM
| ID: wpr-215894
ABSTRACT
Takayasu's arteritis (TA), a granulomatous vasculitis, affects the aorta and its major branches. Glucocorticoids are an effective treatment for patients with active TA, but some patients fail to achieve or maintain remission with the conventional therapy, and side effects resulting from long-term glucocorticoid therapy are potentially serious. Anti-tumor necrosis factor-alpha agents, such as infliximab, may be efficient in patients with refractory TA. We report on a 24-year-old female patient with refractory TA who was treated successfully with infliximab. Clinical remission was induced as determined by repeated 18F-fluoro-2-deoxy-D-glucose positron emission tomography scans combined with assay of serological inflammatory markers.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Aorta
/
Vasculite
/
Arterite de Takayasu
/
Tomografia por Emissão de Pósitrons
/
Infliximab
/
Glucocorticoides
/
Anticorpos Monoclonais
/
Necrose
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Journal of Rheumatic Diseases
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS